Agenda Clinical Hematology & Oncology 2025

5-7 p.m.                             

Welcome Dinner

Join us in the Del Mar breakout room for a complimentary dinner

7 a.m.                 

Registration, Breakfast & View Exhibits

7:55 a.m.                           

Welcome & Educational Overview

8 a.m.                 

Peri-operative Thrombocytopenia          

8:30 a.m.                           

Hormonal Therapy and Thrombosis Risk              

9 a.m.                 

Barely Abnormal CBCs  

9:30 a.m.                           

Panel Discussion/Q&A  

10 a.m.               

Break & View Exhibits

10:15 a.m.         

Antiphospholipid Syndrome: 2024 Update         

10:45 a.m.         

Hypereosinophilic Syndrome     

11:15 a.m.         

Investigating Bleeding of an Obscure Cause        

11:45 a.m.         

Panel Discussion/Q&A

12 p.m.               

Lunch

1 p.m.                 

What’s New in AML       

1:30 p.m.                           

Should Patients Still Undergo BMT for Myeloma?

2 p.m.                 

Evolving Therapeutic Approaches in Patients with Low-risk MDS             

2:30 p.m.                           

Panel Discussion/Q&A

2:45 p.m.                           

Break & View Exhibits

3:15 p.m.                           

Clinical Ipdates in B-ALL

3:45 p.m.                           

Refractory Diffuse Large Cell Lymphoma             

4:15 p.m.                           

HLH and HLH-like Inflammatory Syndromes       

4:45 p.m.          

Panel Discussion/Q&A

CONCURRENT BREAKOUT SESSIONS

5:15 p.m.           

Breakout #1: Interesting Cases in Thrombosis

Breakout #2: Interesting Cases in Platelet Disorders

Breakout #3: Interesting Cases in Bleeding

Breakout #4: Interesting Cases in Plasma Cell Dyscrasias

6:15 p.m.

Adjourn

7 a.m.                 

Breakfast & View Exhibits

7:55 a.m.                           

Welcome & Announcements

8 a.m.                 

Ultra Low Her2 Breast Cancer: Pushing the Boundary in IHC 0 and Treatment Implications              

8:30 a.m.                           

Changing Landscape of Sequencing in HR Positive, Her2 Negative Metastatic Breast Cancer              

9 a.m.                 

Sequencing Therapies in Early Triple Negative Breast Cancer      

9:30 a.m.                           

Panel Discussion/Q&A

10 a.m.               

Break & View Exhibits

10:30 a.m.         

Neoadjuvant and Adjuvant Therapy for Melanoma         

11 a.m.               

Management of Variant Histology Renal Cell Carcinoma

11:30 a.m.         

Targeted Therapies in Central Nervous System Metastasis

Noon                   

Panel Discussion/Q&A

12:30 p.m.         

Lunch

1:30 p.m.                           

Rectal Cancer – Making Sense of TNT, ctDNA, and Surgery: A Case-based, Multidisciplinary Discussion          

3:30 p.m.            

Panel Discussion/Q&A  

3:30 p.m.                           

Break & View Exhibits

4 p.m.                 

New Targeted Therapies for Gastroesophageal Cancer

4:30 p.m.                           

TBD

5 p.m.                

Panel Discussion/Q&A

5:30 p.m.                           

Adjourn

7 a.m.                 

Breakfast & View Exhibits

7:55 a.m.                           

Welcome & Announcements

8 a.m.                 

Role of Immune Therapy in Advanced Endometrial Cancer         

8:30 a.m.                           

Updates in the Treatment of Metastatic Soft Tissue Sarcoma     

9 a.m.                 

Genomic Risk Stratification and High Sensitivity Imaging in Localized Prostate Cancer    

9:30 a.m.                           

Panel Discussion/Q&A

10 a.m.               

Break & View Exhibits

10:30 a.m.         

Optimal Management of ALK Rearranged NSCLC             

11 a.m.               

Evidence-Based Management of Hormone Deprivation Symptoms After Cancer

11:30 a.m.         

Management of Common Skin-related Side Effects of Cancer Treatment               

Noon                   

Panel Discussion/Q&A

12:30 p.m.         

Final Adjournment

Please note: All times are listed in Pacific Time (PT). Topics, times and speakers are subject to change.